Novo Nordisk's new anti-obesity drug spurs high demand
By
Alain Thériault
|
Aug. 14, 2024, 10:58 a.m.
Flash |
Supplementary health insurance |
Drug insurance |
Life Insurance |
TELUS |
CANADIAN LIFE AND HEALTH INSURANCE ASSOCIATION (CLHIA) |
SUN LIFE FINANCIAL |
CANADA LIFE |
DESJARDINS |
C.D. HOWE INSTITUTE |
GREENSHIELD |
MEDAVIE BLUE CROSS |
RÉGIE DE L’ASSURANCE MALADIE DU QUÉBEC (RAMQ) |
ONTARIO DRUG BENEFIT PROGRAM |
BENEVA |
MANULIFE |
FRASER GROUP |
Medication |
International
Photo: Unsplash | Diana Polekhina
This article is reserved to PRO Level subscribers
Discover the PRO Level
Already subscribed? Sign in >
You are already subscribed
If your access is suspended, please verify and update your credit card in your profile.
×
Advertisement
The most popular in Health
Make your business shine with Visibility360!
Get a PDF version to share in your networks.
I'm interestedHeadlines
Advertisement
Related topics …